Benign (non-invasive) or malignant (cancerous) ovarian tumours
Disease of the adrenal gland
Partial deficiency of the adrenal enzyme 21-hydroxylase (late onset CYP21A2 deficiency) and other forms of congenital adrenal hyperplasia
Benign or malignant adrenal tumours
Disease of the pituitary gland
Cushing syndrome due to excessive adrenocorticotrophic hormone (ACTH)
Acromegaly (gigantism) due to excessive growth hormone and insulin-like growth factor (IFG-1)
Prolactinoma, a tumour that produces prolactin, as prolactin stimulates the adrenal gland
Obesity and the metabolic syndrome – more androgens are made by the adrenals and in body fat in response to release of insulin and IFG-1, and less vitamin-D is produced in the skin
The mechanisms that result in hyperandrogenism may involve:
High overall levels of circulating testosterone
Normal overall testosterone but increased free testosterone, due to low levels of circulating sex-hormone-binding-globulin (SHBG, the protein that carries testosterone in the blood). Normally there is little free testosterone circulating in the blood as testosterone is tightly bound by SHBG
More active conversion of weaker androgens to stronger androgens such as dihydroxytestosterone (DHT) by the enzyme Type 1 5-alpha-reductase within the sebaceous gland
Adrenal steroids converted first to androstenedione by 3-beta-hydroxysteroid dehydrogenase then to testosterone by 17-beta hydroxysteroid dehydrogenase.
The higher sensitivity of the skin to DHT
Effects of insulin and IGF-1
What are the effects of hyperandrogenism?
Hyperandrogenism can lead to any or all of the following:
Masculine appearance with increased muscle mass and decreased breast size
Deepening of voice with prominent larynx (voice box)
Clitoral enlargement associated with increased libido (virilisation)
Infertility
Associated type 2 diabetes due to insulin resistance
Obesity
Acne
Hirsutism
Pattern alopecia
What tests are necessary to confirm hyperandrogenism?
If there are symptoms or signs to suggest hyperandrogenism, baselinelaboratory investigations may be useful to identify the exact cause.
Blood tests for hormones:
FSH (follicle stimulating hormone)
LH (luteinising hormone)
Oestradiol
Prolactin
Testosterone
SHBG (sex hormone binding globulin)
17-hydroxyprogesterone
DHEAS
Thyroid function.
Pelvic ultrasound scan to evaluate ovarian cysts
The oral contraceptive should be stopped 6 weeks before testing. The ideal time is in the first 3 days of the menstrual period and the sample is best taken when fasting.
Elevated testosterone suggests an ovarian source may be responsible for the signs of hyperandrogenism. If the levels of testosterone are only mildly elevated, consider polycystic ovary syndrome, if they are markedly elevated, consider an ovarian tumour.
Elevated DHEAS suggests an adrenal source and an elevated 17-hydroxyprogesterone level suggests congenital adrenal hyperplasia.
My test results are normal. Why do I have acne/hirsutism?
Most females with acne/hirsutism have similar levels of hormones to unaffected women. This indicates their acne/hirsutism is not due to disease of the ovary, adrenal gland or pituitary gland.
Some women have more activity of the enzyme 5-reductase within their sebaceous glands. This leads to more male hormone dihydrotestosterone within the cell, which can explain acne and hirsutism. Other causes of acne include hereditary and environmental factors.
Should I consult a hormone specialist?
Most women with acne and/or hirsutism can be managed by a family doctor/GP or by a dermatologist.
Patients with acne and significant menstrual disturbance, severe hirsutism, suspected Cushing syndrome or acromegaly, total testosterone of > 5 nmol/L or other hormone abnormalities are best to consult an endocrinologist (hormone specialist).
Most women with hirsutism use physical methods of hair removal and may take the birth control pill.
However, when acne and/or hirsutism are unresponsive to conventional therapy because of hormone imbalances, more potent antiandrogensmay be considered.
References
Lakshmi C. Hormone therapy in acne. Indian J Dermatol Venereol Leprol. 2013 May-Jun;79(3):322–37. doi: 10.4103/0378-6323.110765. Review. PubMed PMID: 23619437.